Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Hyperprolactinemia Induced by Antipsychotic Drugs on Bone Metabolism

NCT03675750 is registered in ClinicalTrials.gov with Shanghai Mental Health Center as lead sponsor.

NCT NCT03675750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03675750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Hyperprolactinemia Induced by Antipsychotic Drugs on Bone Metabolism
Lead sponsor
Shanghai Mental Health Center
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2018
Completion date
October 31, 2020
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia